A Randomized, Blinded, Controlled Trial of Music Therapy Singing Interventions for Patients With MCI and AD

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study compares different music therapy (MT) experiences and their impact on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment. The 12-month study will assess the role of common experiences involving familiar music and other pleasant events (blinded control) to benefit cognition and measure the quality of life for people with Alzheimer's disease and Mild Cognitive Impairment. Following screening, all participants will meet with a licensed music therapist at the first study visit. Thereafter, each group will have an individualized schedule of follow-up telephone calls and visits. Screening for the study and participation in the study intervention can be completed in-person or from your home, if you do not live in the area.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 55
Healthy Volunteers: f
View:

• Diagnosis of Alzheimer's disease or mild cognitive impairment

• Must have study partner

• English speaking

• No verbal impairment

• Community-dwelling

• Must have webcam or smart phone

Locations
United States
New York
Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai
RECRUITING
New York
Louis Armstrong Center for Music and Medicine, Mount Sinai Beth Israel
RECRUITING
New York
Contact Information
Primary
Adeleine Dauray
adeleine.dauray@mssm.edu
212-241-8329
Time Frame
Start Date: 2019-08-27
Estimated Completion Date: 2025-07
Participants
Target number of participants: 100
Treatments
Experimental: Home-based MT through Supervised, Supported Singing (H3S)
Treatment arm 1
Experimental: H3S and IMT
Treatment arm 2 received both Home-based Supervised, Supported Singing (H3S) and Individualized Music Therapy (IMT)
Placebo_comparator: Attention Control (AtCon)
Comparison condition with comparable attention
Related Therapeutic Areas
Sponsors
Leads: Icahn School of Medicine at Mount Sinai

This content was sourced from clinicaltrials.gov